- Home
- PROF vs AVTX Comparison
PROF vs AVTX Comparison
Compare PROF & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- AVTX
- Stock Information
- Founded
- PROF N/A
- AVTX 2011
- Country
- PROF Canada
- AVTX United States
- Employees
- PROF N/A
- AVTX N/A
- Industry
- PROF Medical/Dental Instruments
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- PROF Health Care
- AVTX Health Care
- Exchange
- PROF Nasdaq
- AVTX Nasdaq
- Market Cap
- PROF 134.3M
- AVTX 138.8M
- IPO Year
- PROF N/A
- AVTX 2015
- Fundamental
- Price
- PROF $4.09
- AVTX $10.14
- Analyst Decision
- PROF Strong Buy
- AVTX Strong Buy
- Analyst Count
- PROF 1
- AVTX 8
- Target Price
- PROF $11.00
- AVTX $31.00
- AVG Volume (30 Days)
- PROF 181.3K
- AVTX 168.1K
- Earning Date
- PROF 11-06-2025
- AVTX 11-06-2025
- Dividend Yield
- PROF N/A
- AVTX N/A
- EPS Growth
- PROF N/A
- AVTX N/A
- EPS
- PROF N/A
- AVTX N/A
- Revenue
- PROF $11,840,000.00
- AVTX $441,000.00
- Revenue This Year
- PROF $60.07
- AVTX N/A
- Revenue Next Year
- PROF $121.80
- AVTX N/A
- P/E Ratio
- PROF N/A
- AVTX N/A
- Revenue Growth
- PROF 59.81
- AVTX N/A
- 52 Week Low
- PROF $3.76
- AVTX $3.39
- 52 Week High
- PROF $9.17
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- PROF 35.14
- AVTX 54.75
- Support Level
- PROF $3.76
- AVTX $8.65
- Resistance Level
- PROF $4.69
- AVTX $12.41
- Average True Range (ATR)
- PROF 0.19
- AVTX 0.92
- MACD
- PROF -0.00
- AVTX -0.08
- Stochastic Oscillator
- PROF 33.67
- AVTX 39.63
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).